Anita Jeyam

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

Stuart J. McGurnaghan, Amanda Weir, Jen Bishop et al. · The Lancet Diabetes & Endocrinology · 2020 · 341 citations · Full text

Public Health, Chronic Disease Prevention, Preventive Medicine +12

Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications

Anita Jeyam, Helen M. Colhoun, Luke A. K. Blackbourn et al. · Diabetes Care · 2020 · 111 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: Recommendations to minimize the functional consequences

Paola Anzellotti, Marta L. Capone, Anita Jeyam et al. · Arthritis & Rheumatism · 2010 · 64 citations

Medicine, Pharmacology, Pharmacotherapy +16

Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016

Colette Mair, Wahyu Wulaningsih, Anita Jeyam et al. · Diabetologia · 2019 · 62 citations · Full text

Medicine, Chronic Disease Control, Endocrinology +16

Diabetic Neuropathy Is a Substantial Burden in People With Type 1 Diabetes and Is Strongly Associated With Socioeconomic Disadvantage: A Population-Representative Study From Scotland

Anita Jeyam, Stuart J. McGurnaghan, Luke A. K. Blackbourn et al. · Diabetes Care · 2020 · 57 citations · Full text

Medicine, Neurology, Diabetology +15